患有多发性骨髓瘤的患者传播性血管内凝血的危险因素和预测模型
Rong Bao1, Mengtong Fan2, Min Hu1
1Department of Clinical Laboratory, First Hospital of Shanxi Medical University, Taiyuan, China.
概括
这项研究发现,16.8%的多发性骨髓瘤患者患有扩散性血管内凝血 (DIC). 使用前热血素时间,纤维素降解产物和D-二次体的预测公式可以识别高风险患者.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 凝血科学 凝血科学
背景情况:
- 多发性骨髓瘤 (MM) 是一种显著的血液性恶性瘤.
- 患有MM的患者面临患有扩散性血管内凝血 (DIC) 的高风险.
- 在MM中,DIC是一种严重的并发症,涉及全身凝血,微血栓,器官功能障碍和出血.
研究的目的:
- 为了确定多发性骨髓瘤患者中DIC的发生率.
- 确定与MM中DIC发展相关的关键风险因素.
- 创建一个预测公式来评估MM患者的DIC风险.
主要方法:
- 对多发性骨髓瘤患者数据的回顾性分析.
- 后勤回归分析以确定重要的DIC风险因素.
- 接收器操作特征 (ROC) 曲线分析以评估模型预测能力.
主要成果:
- 住院MM患者中DIC的发生率为16.8%.
- 输血红素时间 (PT),纤维素降解产物 (FDP) 和D-二元水平是DIC的显著预测因素.
- 开发的预测模型表现出强大的歧视力,AUC为0.927.
结论:
- 一种新的预测公式可以帮助早期识别患有DIC高风险的MM患者.
- 该公式基于后勤回归,为临床风险评估提供了有价值的工具.
- 需要进一步验证和改进,以提高配方的准确性和临床效用.
关键词:
D-二聚子 D-二聚子扩散的血管内凝血.纤维素降解产品中的纤维素降解产品.逻辑回归的逻辑回归方法多发性骨髓瘤是多发性骨髓瘤的一种.预测模型是一个预测模型.蛋白质血时间 (prothrombin time) 是什么?更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.6K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.8K
相关概念视频
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
